Icahn School of Medicine at Mount Sinai

Icahn School of Medicine at Mount Sinai Excellence in research, education and patient care are hallmarks of our educational philosophy. Our students are tomorrow's leaders. News & World Report.
(448)

To contact the admissions office, please email admissions@mssm.edu As one of the nation’s leading medical schools, Icahn School of Medicine at Mount Sinai ranks 18th out of 126 medical schools nationwide, according to U.S. We have built our reputation on a tradition of excellence inspired by visionary leaders, esteemed faculty, and outstanding trainees. Our progressive curriculum stresses a compassionate and collaborative approach to medical practice and scientific investigation. Find out more about the educational opportunities available to you as a student at Icahn School of Medicine at Mount Sinai. Learn more at http://icahn.mssm.edu

Join us for a one-day CME course offering a comprehensive update on fertility care, from recurrent pregnancy loss and fe...
01/09/2026

Join us for a one-day CME course offering a comprehensive update on fertility care, from recurrent pregnancy loss and fertility preservation to oncofertility, genetics, and LGBTQIA+ family-building. Led by experts from RMA of New York and the Department of OB/GYN at Mount Sinai, this program blends clinical expertise with patient perspectives to support confident counseling, diagnosis, and referral across specialties.

Friday, January 30, 2026 | 7:00 AM–1:35 PM
Davis Auditorium, New York, NY
Find out more and register: https://mshs.co/4sxiole

Designed for a broad range of clinicians and health care professionals involved in patient-centered reproductive care.

Save the date! Join us on Friday, May 15, 2026, for the Mount Sinai Fuster Heart Research Forum: “The Next Era of Cardio...
01/08/2026

Save the date! Join us on Friday, May 15, 2026, for the Mount Sinai Fuster Heart Research Forum: “The Next Era of Cardiovascular Research: Discovery, Innovation & Patient Care.” Dive into a full day of exploring the latest breakthroughs in cardiology, clinical research, basic science, and translational science—all shaping the future of heart health.

01/07/2026

Applications are now open for the PhD Program in Health Sciences & Engineering (HSE), offered in partnership with Rensselaer Polytechnic Institute. This interdisciplinary program trains the next generation of leaders at the intersection of engineering, medicine, and translational science, with focused tracks in immuno-engineering, neuro-engineering, and reparative/regenerative medicine.

The application deadline has been extended to January 15, 2026. Apply now: https://mshs.co/3DkfT0q

Learn more about the program: https://mshs.co/41xnHX4

We are proud to announce that Mount Sinai microbiologist Florian Krammer, PhD, has been elected a Class of 2025 Fellow o...
01/06/2026

We are proud to announce that Mount Sinai microbiologist Florian Krammer, PhD, has been elected a Class of 2025 Fellow of the National Academy of Inventors (NAI)—the highest professional distinction awarded solely to inventors.

This prestigious honor recognizes Dr. Krammer’s exceptional contributions to innovation and his impact in translating scientific discovery into solutions that improve lives. He joins a distinguished cohort of inventors whose work spans every major field of discovery.

A Professor of Vaccinology in the Department of Microbiology at the Icahn School of Medicine at Mount Sinai, Dr. Krammer leads groundbreaking research on influenza and RNA virus vaccines, including efforts to advance universal influenza vaccines toward clinical application.

Dr. Krammer will be formally inducted at the NAI Annual Conference in Los Angeles.

Momentum on Icahn School Connect continues to grow. Since the platform relaunch, more than 200 alumni have created profi...
01/03/2026

Momentum on Icahn School Connect continues to grow. Since the platform relaunch, more than 200 alumni have created profiles — strengthening a network that now includes over 1,000 alumni. Seven alumni–student matches have already been made, including five in the past month alone, marking a 150% increase in connections.

Students can more easily find advisors aligned with their career goals, alumni can support the next generation while reconnecting with peers, and faculty can build meaningful mentoring relationships across the Mount Sinai community.

Mount Sinai is advancing the management of benign prostatic hyperplasia (BPH) through the adoption of innovative diagnos...
01/02/2026

Mount Sinai is advancing the management of benign prostatic hyperplasia (BPH) through the adoption of innovative diagnostic tools, minimally invasive therapies, and technology-enabled care models designed to meet the diverse needs of an aging male population. By integrating new treatment platforms such as the Optilume® BPH Catheter System, next-generation robotic surgical technologies, and AI-driven disease management applications, Mount Sinai physicians are expanding therapeutic options while prioritizing safety, effectiveness, and quality of life. These coordinated efforts underscore the institution’s commitment to personalized, evidence-based urologic care and to delivering durable symptom relief through continual clinical innovation.

Mount Sinai researchers are exploring the potential of dupilumab—an FDA-approved therapy for asthma and allergic disease...
12/29/2025

Mount Sinai researchers are exploring the potential of dupilumab—an FDA-approved therapy for asthma and allergic disease—as a novel strategy in the fight against non-small cell lung cancer. Led by Thomas Marron, MD, PhD, Professor of Medicine and Immunology and Immunotherapy at the Icahn School of Medicine at Mount Sinai, this research examines whether targeting type 2 inflammation through IL-4 signaling blockade can reduce lung cancer risk among patients with eosinophilic chronic obstructive pulmonary disease (COPD), a population already at high risk due to smoking history and underlying inflammatory biology.

Through a multidisciplinary collaboration across oncology, pulmonology, and immunology, the study reflects Mount Sinai’s commitment to advancing immune-based prevention and precision medicine. By investigating whether dupilumab can slow or reverse the growth of precancerous lung nodules—while also improving respiratory symptoms—this work aims to shift the paradigm from early cancer detection to true cancer prevention.

Mount Sinai interventional pulmonologists are setting a new standard in lung nodule diagnosis by integrating robotic bro...
12/26/2025

Mount Sinai interventional pulmonologists are setting a new standard in lung nodule diagnosis by integrating robotic bronchoscopy with cryobiopsy, a technique that markedly improves diagnostic yield without compromising patient safety. Led by Udit Chaddha, MBBS, Associate Director of Interventional Pulmonology at the Icahn School of Medicine at Mount Sinai, this advanced approach allows clinicians to obtain larger, better-preserved tissue samples from hard-to-reach areas of the lung, supporting more accurate diagnoses and comprehensive molecular testing for precision oncology.

By combining state-of-the-art navigation technologies with cryobiopsy, Mount Sinai physicians are achieving definitive diagnoses in a substantially higher proportion of cases while maintaining very low complication rates. This innovation reflects Mount Sinai’s commitment to advancing minimally invasive diagnostics and delivering safer, more effective care for patients with suspected lung disease.

Learn more: https://mshs.co/4sadmLc

Mount Sinai is expanding access to integrated, youth-centered mental health and substance use care through the Comprehen...
12/22/2025

Mount Sinai is expanding access to integrated, youth-centered mental health and substance use care through the Comprehensive Adolescent Rehabilitation and Education Service (CARES). With a new partnership launching in January 2026 with the Youth Shelter Program of Westchester, CARES will extend its multidisciplinary, evidence-based model beyond school settings to reach young people who often face fragmented or siloed care. Led by Shilpa R. Taufique, PhD, the program has supported New York City students for more than three decades by addressing mental health, substance use, and educational needs together—helping youths build stability, resilience, and long-term opportunity.

This expansion reflects Mount Sinai’s continued commitment to community-based, whole-person care for adolescents, particularly those facing complex social and behavioral health challenges. By adapting the CARES model to new environments, the team aims to demonstrate how integrated care can be delivered flexibly across diverse settings while maintaining strong clinical and educational outcomes.

Mount Sinai researcher Nilsson Holguin, PhD, is uncovering a critical—and long overlooked—connection between alpha-1 ant...
12/20/2025

Mount Sinai researcher Nilsson Holguin, PhD, is uncovering a critical—and long overlooked—connection between alpha-1 antitrypsin deficiency (AATD) and osteoporosis. Supported by a new grant from the Alpha-1 Foundation, Dr. Holguin’s work is redefining understanding of this rare genetic disorder, revealing musculoskeletal risks even in individuals with mild or moderate AATD. Through advanced imaging, innovative mouse models, and investigations into potential treatments, his research aims to identify new therapeutic pathways for alpha-1–related osteoporosis and deepen insights into age-related spine degeneration.

We are proud to celebrate two outstanding Mount Sinai alumni whose careers exemplify the power of rigorous training, inn...
12/19/2025

We are proud to celebrate two outstanding Mount Sinai alumni whose careers exemplify the power of rigorous training, innovation, and service to society.

Maudry Laurent-Rolle, MD, PhD, a graduate of the Medical Scientist Training Program, is a leading viral immunologist whose work on arboviral diseases is advancing our understanding of emerging infections. Equally impactful is her commitment to mentoring the next generation of scientists—reflecting the enduring influence of Mount Sinai–trained physician-scientists.

Anne M. Neilan, MD, MPH, a graduate of the MD and MPH programs, bridges clinical care and innovative research to improve HIV outcomes for adolescents and young adults worldwide. Her work highlights the essential role of clinician-researchers in shaping the future of global public health.

Icahn School Connect is strengthening the global Icahn School of Medicine at Mount Sinai community by making mentorship ...
12/19/2025

Icahn School Connect is strengthening the global Icahn School of Medicine at Mount Sinai community by making mentorship more accessible than ever. This easy-to-use online platform brings together students, alumni, and faculty to foster meaningful advising relationships that support career growth, exploration, and academic development.

With more than 1,000 alumni currently on the platform—and growing—Icahn Connect is your pathway to deeper engagement across our institution. Whether you’re a student seeking guidance, an alumnus looking to give back, or a faculty member interested in building new mentoring connections, there’s a place for you here.

Join today and start building the professional relationships that shape futures by heading to our link in bio.

Address

1468 Madison Avenue
New York, NY
10029

Website

Alerts

Be the first to know and let us send you an email when Icahn School of Medicine at Mount Sinai posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Icahn School of Medicine at Mount Sinai:

Shortcuts

Featured

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category